Posts

Sales Compensation Strategy: How Data and Analytics Consulting Strengthens Plan Design

  Sales compensation is one of the biggest levers a company has for shaping seller behavior — and one of the easiest to get wrong. Plans built on outdated assumptions, incomplete data, or gut instinct often end up too generous, too complex, or misaligned with what the business actually needs reps to do. That’s where data and analytics consulting comes in: using benchmarking, predictive modeling, and performance analysis to inform how compensation plans are structured and adjusted over time. This article explains what sales compensation involves, where data and analytics consulting adds measurable value, and what to consider when bringing in outside analytical support. What Sales Compensation Includes Sales compensation refers to the combination of base salary, commission, bonuses, and other incentives that reward sales performance. A sales compensation plan typically defines quotas, commission rates or tiers, accelerators for exceeding targets, and the specific metrics — revenue, n...
Post a Comment
Read more

Drug Discovery Consulting and Clinical Trial Consulting: What Sponsors Should Know Before Engaging an Advisor

  Drug discovery consulting and clinical trial consulting both help organizations make better decisions in a field where decisions are expensive and hard to reverse. Discovery-stage teams ask whether a target and candidate justify further investment. Clinical teams ask whether a trial design, site strategy, and data plan can answer the questions regulators and payers will care about. This article explains what each type of advisory typically covers, how they connect, and how to select and measure a partner. What Drug Discovery Consulting Typically Involves Drug discovery consulting supports the early path from biological hypothesis to development candidate. Common areas include: •       Target identification and validation: reviewing the evidence that a target is relevant to a disease and tractable. •       Assay and screening strategy: assessing whether experiments will produce reliable, decision-ready data. •       Hit-to-lead an...
Post a Comment
Read more

The Future of Health: Why Pharma and Life Sciences Leaders Are Rethinking Their Commercial Strategy

  Healthcare is being rebuilt in real time. Patent cliffs are compressing revenue windows, patients are behaving more like consumers, and artificial intelligence is quietly becoming the interface between clinicians and clinical information. For pharmaceutical and life sciences executives, the question is no longer whether the industry will change — it's whether their organization is structured to keep pace with it. That question is exactly why healthcare consulting firms have moved from a peripheral resource to a core part of how leading companies plan their next five years. Why the Future of Health Is a Strategic Question, Not Just a Clinical One It's tempting to think of the future of health as a story about science — new modalities, faster trials, better diagnostics. That's part of it, but the bigger shift is commercial and operational. Manufacturers are being asked to prove value, not just efficacy, to a widening circle of payers, providers, and increasingly price-sens...
Post a Comment
Read more

Modernizing Life Sciences R&D: Where Digital Technology Creates Real Value

Image
Pharmaceutical and biotechnology companies face an uncomfortable reality: scientific innovation can move rapidly while the processes used to manage research remain fragmented, manual, and difficult to scale. Across life sciences research and development , organizations are managing increasingly complex datasets, specialized scientific workflows, clinical programs, regulatory requirements, and collaboration networks. At the same time, executives are expected to improve productivity without compromising scientific rigor or patient safety. This is where digital technology consulting can help—but only when technology is applied to a clearly defined R&D problem. The objective should not be to digitize everything. It should be to improve how scientific work gets done. Where R&D Organizations Commonly Struggle R&D organizations often operate through a collection of systems developed at different times for different purposes. A research team may use specialized laboratory tools. Cl...
Post a Comment
Read more